Effectiveness of online HIV treatment services in the context of the COVID‐19 pandemic

Author:

Han Jing1,Zhang Hanxi1ORCID,Su Ye1,Zhang Fujie2

Affiliation:

1. WHO Collaborating Centre for Comprehensive Management of HIV Treatment and Care Beijing Ditan Hospital Capital Medical University Beijing China

2. Center for HIV/AIDS Beijing Ditan Hospital Capital Medical University Beijing China

Abstract

AbstractBackgroundThe COVID‐19 pandemic has created challenges with respect to HIV care services. Remote online services might provide an effective method for health service delivery to people living with HIV (PLHIV). Few studies have focused on the efficacy of telemedical services for PLHIV and the effect of antiretroviral treatment via online services in China.MethodsWe developed a platform called the “No. 8 Health” for online antiretroviral drug collection and delivery services in Beijing from January 21 to June 30, 2022. We evaluated the online treatment service according to viral load suppression rates and compared differences in social characteristics between PLHIV who received antiretroviral drugs through online or offline treatment services.ResultsBy June 2022, 9528 PLHIV had received outpatient treatment services, among which 44.6% (4031/9528) used the online treatment and drug delivery services for a total of 5590 person‐times. The satisfaction rate was 100%. Rates of viral load suppression among PLHIV who initiated antiretroviral therapy (ART) in 2020 and 2021 were 96.4% and 93.1%, respectively. Results showed that the viral load suppression rate was 97.9%. Regarding HIV rapid self‐testing, 4513 men who have sex with men used the online HIV rapid testing service. The number of users was approximately the same as in 2021, but both were slightly lower than those in 2020.ConclusionThis study was the first to evaluate the effect of online drug collection and delivery services and virologic outcomes among PLHIV in China. The online service helped with maintenance of ART services, but the COVID‐19 pandemic still had some impacts on viral load suppression.

Publisher

Wiley

Reference23 articles.

1. UNAIDS. COVID‐19 AND HIV: 1 MOMENT 2 EPIDEMICS 3 OPPORTUNITIES.2020. Available from:https://www.unaids.org/sites/default/files/media_asset/20200909_Lessons-HIV-COVID19.pdf

2. UNAIDS. Global AIDS Strategy 2021–2026 End Inequalities End AIDS. Available from:https://www.unaids.org/sites/default/files/media_asset/global-AIDS-strategy-2021-2026_en.pdf. Accessed 3 December2021.

3. UNAIDS. UNAIDS. 90–90–90: good progress but the world is off‐track for hitting the 2020 targets. Available from:https://www.unaids.org/en/resources/presscentre/featurestories/2020/september/20200921_90-90-90. Accessed 5 March2021.

4. COVID-19 Lockdowns: Impact on Facility-Based HIV Testing and the Case for the Scaling Up of Home-Based Testing Services in Sub-Saharan Africa

5. Challenges and opportunities brought by COVID‐19 to the prevention and treatment of other infectious disease;Jian Xu;Mod Prev Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3